GlassScriptPhysician profile
Ema Zubovic
NPI 1417307646
$2,837.43
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,496 · 2020: $285 · 2022: $693 · 2023: $339 · 2024: $24.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $363.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $711.00 | 2019 | |
| Baxter Healthcare | $448.58 | 2019-2023 | Biosurgery - Tisseel |
| Integra Lifesciences Corporation | $259.06 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Sientra, INC. | $258.96 | 2020-2022 | |
| Stryker Corporation | $202.89 | 2019-2022 | |
| Axogen | $196.98 | 2019-2020 | |
| Davol INC. | $150.03 | 2022 | |
| Kci USA, INC. | $143.21 | 2022-2023 | V.A.C. Veraflo, Prevena, Prevena Restor Bellaform |
| Acera Surgical, INC. | $134.41 | 2022 | |
| Acell, INC. | $90.19 | 2019 | |
| Zimmer Biomet Holdings, INC. | $76.69 | 2019 | |
| Mentor Worldwide LLC | $73.22 | 2019 | |
| Misonix INC | $67.57 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $24.64 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ema Zubovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.